Search results
Showing 7591 to 7605 of 8213 results
Digital technologies for multidisciplinary weight management
In development Reference number: GID-HTE10077 Expected publication date: TBC
In development Reference number: GID-TA11663 Expected publication date: TBC
Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults (IPG482)
This guidance has been updated and replaced by NICE interventional procedures guidance 807, 808 and 810.
myCOPD for managing chronic obstructive pulmonary disease (MTG68)
This guidance has been updated and replaced by NICE healthtech guidance 736, which covers using myCOPD for self-management of chronic obstructure pulmonary disease (COPD), and NICE healthtech guidance 718, which covers using myCOPD for pulmonary rehabilitation.
Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease (MIB300)
This advice has been updated and replaced by NICE healthtech guidance 736.
Artificial intelligence for analysing chest X-ray images (MIB292)
This medtech innovation briefing has been updated and replaced by HealthTech guidance 696.
Space from Depression for treating adults with depression (MIB215)
This advice has been updated and replaced by NICE HealthTech guidance 675.
Discontinued Reference number: GID-TA11008
NICE has retired this cancer service guideline because the recommendations are no longer being kept up to date and may no longer reflect best practice.Retired guidance is no longer being actively maintained. The guidance has no status, and the health and care system is not expected to follow it. Retired guidance is available as a PDF for reference only.
Improving supportive and palliative care for adults with cancer (CSG4)
NICE has retired this cancer service guideline because the recommendations are no longer being kept up to date and may no longer reflect best practice.Retired guidance is no longer being actively maintained. The guidance has no status, and the health and care system is not expected to follow it. Retired guidance is available as a PDF for reference only.
NICE has retired this cancer service guideline because the recommendations are no longer being kept up to date and may no longer reflect best practice.Retired guidance is no longer being actively maintained. The guidance has no status, and the health and care system is not expected to follow it. Retired guidance is available as a PDF for reference only.
Discontinued Reference number: GID-PHG59
Pirtobrutinib for treating relapsed or refractory mantle cell lymphoma [ID3975]
In development Reference number: GID-TA10858 Expected publication date: TBC
Sotagliflozin with insulin for treating type 1 diabetes (TA622)
NICE has withdrawn this guidance. This is because the company is no longer marketing sotagliflozin (Zynquista) and its marketing authorisation has been withdrawn.
In development Reference number: GID-TA11214 Expected publication date: TBC